# Governed Biomedical Research and Development

J.A.R.V.I.S v0.7 implements a persistent biomedical research, invention, external-development, and commercialization workforce for BIO-GENE-style programs.

It is not limited to literature summaries. It preserves the full research-to-value chain while separating analysis, recommendations, owner or principal-investigator decisions, external professional execution, returned evidence, and verification.

## Workforce scope

The Biomedical domain supports:

- Scientific and competitive intelligence
- Disease, subtype, target, pathway, mechanism, biomarker, intervention, delivery, manufacturing, regulatory, and market graphs
- Study provenance, quality scoring, retraction status, bias, controls, replication, limitations, and uncertainty
- Candidate and reviewed scientific claims
- Contradiction ledgers and resolution requirements
- Falsifiable hypothesis development
- Computational, assay, preclinical, analytical, manufacturing, and translational development concepts
- University, HBCU, CRO, CDMO, core-facility, testing-lab, biobank, and consultancy qualification
- NDA, RFI, RFQ, SOW, contract, authorization, execution-status, raw-data return, and result-verification records
- Regulatory pathway maps
- Invention disclosures and IP portfolios
- Grant and government-contract opportunities
- Manufacturing-readiness plans
- Licensing, co-development, research-tool, diagnostic, service, data, software, government, product, acquisition, and spinout commercialization plans
- Recommendation, decision, and verification gates

## BIO-GENE-style operating architecture

The records support the functions represented by BIO-GENE's canonical divisions:

- Constellation — portfolio direction and decision gates
- Sentinel — authority, review, and authorization boundaries
- Atlas — persistent program and event memory
- Nexus — scientific and commercial knowledge graphs
- Veritas — evidence quality, contradictions, and result verification
- Genesis Institute — disease and systems-biology research
- Discovery Institute — literature, patent, trial, competitor, laboratory, regulatory, and opportunity intelligence
- Forge Laboratories — molecular, protein, RNA, gene-regulation, formulation, delivery, biomaterial, and intervention concepts
- Helix Laboratories — translation, biomarkers, models, endpoints, toxicology and clinical-development planning
- Foundry — manufacturing science, quality attributes, analytical methods, stability, scale-up, and technology transfer
- Titan Engineering — devices, diagnostics, sensors, microfluidics, delivery systems, and research automation
- Alliance — laboratory and strategic partnerships
- Catalyst — grants, government contracts, budgets, and funding strategy
- Venture — commercialization, licensing, services, products, and spinouts

These are operating functions inside one governed platform, not separate uncoordinated applications.

## Evidence lifecycle

```text
candidate source
  -> provenance and retraction review
  -> deterministic quality assessment
  -> approved, rejected, or retracted
  -> bounded scientific claim
  -> human claim review
  -> hypothesis and contradiction mapping
  -> development decision
```

Approved evidence preserves a provenance hash, source locator, study type, population or model, sample size, endpoints, findings, limitations, conflicts, retraction status, quality score, confidence, reviewer, and review reasoning.

Claims cannot use unreviewed or rejected evidence.

## External laboratory lifecycle

```text
approved development plan
  -> qualified laboratory
  -> capability review
  -> NDA review
  -> RFI
  -> RFQ
  -> SOW review
  -> contracted
  -> explicit owner or principal-investigator authorization
  -> professional external execution
  -> raw data and result package received
  -> independent verification
  -> close, iterate, pivot, license, or terminate
```

Laboratory records preserve capabilities, equipment, quality systems, biosafety levels, certifications, contacts, pricing and availability notes, data-return practices, IP terms, confidentiality readiness, qualification reasoning, and risk flags.

Engagements preserve deliverables, raw-data requirements, quality requirements, chain of custody, budget ceiling, timeline, NDA/RFI/RFQ/SOW/contract references, authorization scope, result references, verification evidence, outcome summary, and every stage transition.

J.A.R.V.I.S does not silently convert a scientific recommendation into a contract, financial commitment, or laboratory authorization.

## Commercial and funding architecture

Every program can maintain both tracks:

```text
Scientific value
  evidence -> hypothesis -> validation -> translation -> impact

Commercial value
  market -> IP -> funding -> partner/customer -> revenue -> reinvestment
```

The system supports earlier revenue strategies such as research tools, diagnostics, services, data products, software, licensing, co-development, and government contracts while longer therapeutic programs mature.

## Permanent eight-node program model

Every research program stores:

1. Input
2. Process
3. Output
4. Feedback
5. Incentives
6. Bottlenecks
7. Dependencies
8. Failure Points

This keeps scientific, operational, funding, and commercial reasoning connected without confusing evidence with certainty.

## Boundaries

The Biomedical domain is designed for legitimate independent and partnered scientific development. It does not block normal professional terms such as formulation, synthesis, gene editing, nanoparticles, dosing evidence, animal models, toxicology, manufacturing, or clinical translation.

Narrow hard stops remain for self-administration workflows, actionable human dosing schedules for untested interventions, oversight evasion, pathogen enhancement, fabricated evidence, autonomous wet-lab execution, and external laboratory commitments without proper authorization.

Physical laboratory work remains with qualified professionals and facilities operating under the applicable contracts, quality systems, biosafety controls, ethics review, and regulatory requirements.

## Persistence

Set:

```text
BIOMEDICAL_STORAGE_DRIVER=postgres
```

Then run:

```bash
npm run migrate
```

The PostgreSQL adapter persists all biomedical entities and append-only events. The migration runner preserves checksums and serializes concurrent migration execution.

## Production work still required

- Production authentication, organizations, roles, and capability tokens
- Encrypted source documents, raw data, contracts, and laboratory reports
- Literature, patent, trial, grant, regulatory, laboratory, CRO, CDMO, and market connectors
- Contract-document workflows and electronic signatures
- Field-level access control for confidential programs and partner data
- Chain-of-custody integrations and sample registries
- LIMS, ELN, QMS, regulatory-information, and manufacturing-system connectors
- Secure approved outbound communication adapters
- Independent legal, regulatory, biosafety, ethics, quality, and scientific review procedures
- Cross-domain approved-artifact transfer into Business Operations, Analytics, Content Production, and Personal Knowledge
